XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.52

-22.9%

Dec 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LarryS who wrote (14205)	7/23/2000 3:28:21 PM
From: Robert K.	of 17367

I would venture a guess that most docs would prefer the DNA drug to the bgen drug. Ease of administration is a issue, but i would certainly prefer a non t cell depleting therapy. What most fail to understand though is the range of possible applications are enormus if this drug works. Psoriasis and transplant are only two of many. And they aint small apps either. Plenty of room for 2 drugs. Last point, and its a important one. You claim dna has more resources. Think deeper, ever hear of Hoffman LaRoche? Do they have resources or motive here? Just IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next